| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries Ltd (TEVA) has 22 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. TEVA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 426.3K | $15.40M | - | |
| CFO | 403.3K | $14.57M | - | |
| Dir | 367.6K | $13.28M | - | |
| VP | 148.8K | $5.38M | - | |
| Dir | 115.7K | $4.18M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2024 | Francis Richard D | President And CEO | Sale+OE | 31,061 | $13.34 | $414,269.88 | -20.1% | +26.3% | +16.7% | |
| Mar 4, 2024 | Conway Vikki L | See "remarks" | Sale+OE | 3,532 | $13.37 | $47,234.50 | -16.2% | +26.3% | +16.7% | |
| Mar 4, 2024 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 95,762 | $13.34 | $1,277,206.52 | -40.7% | +26.3% | +16.7% | |
| Mar 4, 2024 | Hughes Eric A | See "remarks" | Sale+OE | 8,045 | $13.34 | $107,298.58 | -32.3% | +26.3% | +16.7% | |
| Feb 28, 2024 | Drape Eric51 | Executive VP Global Operations | Sale+OE | 9,815 | $13.12 | $128,733.54 | -50.3% | +28.0% | +24.7% | |
| Feb 28, 2024 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 20,599 | $13.12 | $270,176.48 | -22.8% | +28.0% | +24.7% | |
| Feb 28, 2024 | Conway Vikki L | See "remarks" | Sale+OE | 1,366 | $13.12 | $17,916.46 | -31.8% | +28.0% | +24.7% | |
| Feb 16, 2024 | Drape Eric51 | Executive VP Global Operations | Sell | 173,261 | $13.05 | $2,261,905.03 | -100.0% | +25.2% | +24.8% | |
| Feb 15, 2024 | Francis Richard D | President And CEO | Sale+OE | 74,530 | $13.15 | $980,173.84 | -46.1% | +27.1% | +23.1% | |
| Feb 1, 2024 | Weiss Amir | Chief Accounting Officer | Sell | 31,766 | $12.37 | $392,954.95 | -74.8% | +12.2% | +42.3% |